Citation: | Liu Yunchu, . Immunohistochemical Study of Transforming Growth Factor-β2 in Prostatic Cancer[J]. Cancer Research on Prevention and Treatment, 1998, 25(4): 276-278. |
[1] |
Thompson TC. Truong LD.Timme TL,et al.Transforming growth factor β1 as a,biomarker of prostate cancer.J Cellular Bioche,Supplernent,1992,16H:54:
|
[2] |
Hirotake M. et al.Increased expression of genes for basic fibroblast factor type β2 in human begin prostatic hyperplasia.Prostate,1990,16:17
|
[3] |
Thompson TC.Growth lactor and oncogenes in prostate cancer.Cancer Cells.1990,2:345
|
[4] |
Barnard JA.I.yons RM.Moses HL.The cell biology of transforming growth factor bate.Biochim Biophy Acta.1990,1032:79
|
[5] |
Massague J.The transformng growth factor-β family,Annu Rev Cell Biol,1990,6:579
|
[6] |
Centralla M.McCarthy TL.Canalis E. Transfoeming growth factor beta is a bifunctional regularorof replication and collagen stnthesis in osteoblast-enricher cell cultures form letal rat bone.J Bio Chem.1987.262:2869
|
[7] |
Bookstein R.Shew JY.Chen PL.et al.Suppression of tumorigenecity of human prostate corcinm cells by replacing a mutated R B gene.Science.1990.247:712
|
[8] |
Ikeda T.Lionbin MN and Marquardi H.Human transforming growth factor type β2:production by a prostatic adcnocarcinorna cell line, purification and initial characterization.Biochemistry.1984.26:2406
|